Diabetes affects women and girls in different ways throughout their lives. Sex-specific biology, hormonal and metabolic changes across the life course, and social and economic barriers influence their risk of developing diabetes, their access to care and their health outcomes.

Women living with diabetes face a higher relative risk of cardiovascular disease than men with diabetes, as well as kidney and other complications. Timely prevention, diagnosis and ongoing support are therefore essential.

In 2025, the International Diabetes Federation (IDF) established a Working Group on Women and Diabetes. Its members come from five IDF regions, with experts from other regions contributing through Expert Advisory review.

The Working Group is building a global network of clinicians, researchers, advocates and people living with diabetes, which aims, through collaboration, education and advocacy, to strengthen awareness, share knowledge and promote care that meets the needs of women and girls living or at risk of diabetes at every stage of life.

Vision

A world where every woman and girl can prevent diabetes and its complications, access high-quality, appropriate, compassionate care, and live a healthy, fulfilling life at every stage.

Mission

To improve the health and well-being of women and girls affected by or at risk of diabetes by raising awareness, providing guidance and support, promoting gender-responsive care and addressing women’s specific needs throughout life.

Why women and diabetes matter

  • Women experience risk factors and manifestations of diabetes that require greater awareness and attention, including PMOS, gestational diabetes and the metabolic changes of menopause.
  • Despite advances in women’s health, important gaps remain in evidence, understanding and awareness. Clinical guidelines and research have often generalised across sexes, and women remain under-represented in cardiovascular and kidney outcome trials.
  • Women living with diabetes face increased risks, compared to men, of cardiovascular disease, kidney disease and other complications that require timely detection and ongoing care.
  • Social, cultural, economic and policy factors, including cost, transport, caring responsibilities and the lack of gender-sensitive care pathways, can limit women’s access to healthcare, medicines and diabetes education. Even when they reach care, women can be less likely than men to receive recommended tests and treatments.

Objectives and key priorities

Advance research and close evidence gaps

Promote research on diabetes in women and girls, fair representation of women in clinical trials, and data reported separately for women and men. The goal is evidence on risk, treatment response and outcomes that reflect women.

Develop and share guidance

Support practical guidance that addresses women-specific risk factors, clinical needs and experiences of diabetes care, starting with an IDF Position Statement on Women and Diabetes.

Strengthen healthcare professional support

Promote training and practical tools that help healthcare professionals provide informed, compassionate and gender-responsive diabetes care.

Advocate for equitable access to care

Encourage policies and health systems that give women and girls fair access to screening, diagnosis, treatment, essential medicines, diabetes technologies and education. This includes removing the social, cultural, economic and policy barriers that limit their access.

Empower women through knowledge and support

Help women access the information, guidance and tools they need to make informed decisions and take an active role in their health.

A life-course approach to women’s health

The impact of diabetes can change over a woman’s lifetime. Prevention, education, treatment and follow-up should therefore respond to the needs of women at each stage of life.

  • Childhood and adolescence: early detection, support for healthy lifestyles and screening for diabetes risk factors.
  • Reproductive years: attention to menstrual health, polyendocrine metabolic ovarian syndrome (PMOS, formerly polycystic ovary syndrome or PCOS), contraception and family planning, and reduction of risk factors.
  • Pregnancy: preconception care, identification and management of gestational diabetes (GDM), and long-term follow-up.
  • Postpartum: continued support for the health and well-being of mothers and their babies, including follow-up screening after GDM.
  • Midlife transition and perimenopause: recognition of hormonal, weight and metabolic changes that may affect diabetes and cardiovascular risk.
  • Older age: prevention and management of diabetes-related complications, while maintaining physical function, independence and quality of life.

Working Group members

Name Role Country IDF region
Dr Noor Al Busaidi Chair Oman Middle East and North Africa
Dr Hermelinda Pedrosa Deputy Chair Brazil South and Central America
Dr Purvi Chawla Group Secretary India South-East Asia
Dr Jackie Maalouf Member Lebanon Middle East and North Africa
Ms Jane Giles Member Australia Western Pacific
Ms Elena Shelestova Member Georgia Europe
Ms Ana Alvarez Member Spain Europe

The Working Group also uses an Expert Advisory model, through which specialists and advocates from other regions contribute to specific Working Group activities without becoming full members.

Activities

Date Activity
20–22 November 2026 (upcoming) AACE MENA Conference, Dubai: lecture by the Chair, “Beyond Blood Sugar: The Female-Specific Impact of Diabetes Across the Life Course”.
14 November 2026 (upcoming) World Diabetes Day: a Women and Diabetes Working Group poster and educational materials for the public and healthcare professionals.
5 September 2026 DRS 2026, Mumbai: the Chair presented “The Female Face of Diabetes Across the Life Course” in the International Stream on Diabetes Complications curated by IDF. The talk publicly announced the IDF Position Statement on Women and Diabetes and invited experts to contribute.
May 2026 Activity report presented to the 94th IDF Board. The Working Group asked the Board to endorse the scope and development pathway of an IDF Position Statement on Women and Diabetes.

Future direction

The Working Group’s main project is the IDF Position Statement on Women and Diabetes, a global statement focused on sex differences in diabetes across the life course of women and girls, from adolescence to older age.

  • Expert and stakeholder consultation: review of the draft by IDF Member Associations and regional networks, with input from women living with diabetes in each region.
  • Final statement: submitted to the IDF Board for endorsement in early 2027. It will then be published in a peer-reviewed journal and launched at an international event such as the IDF Congress or World Diabetes Day.
  • Global survey of women living with diabetes: planned to measure diabetes knowledge, access to care, barriers to care and unmet needs, and to compare them across regions, income levels, ages and types of diabetes. It is being developed through an expert Delphi process.

In the longer term, the Position Statement will guide further work. This includes clinical guidance, education for healthcare professionals, advocacy and research priorities across IDF regions.